James F. Pingpank Jr. is a board-certified general surgeon who applies novel approaches to the treatment of peritoneal mesothelioma.
- Noted for use of regional therapeutics, a method of attacking cancer by feeding chemotherapy drugs and targeted molecular agents via blood vessels that funnel into a tumor.
- Research focuses on increasing the understanding of role of biomarkers in cancer staging, prognosis and management.
- Authored or co-authored many peer-reviewed journal articles.
- Teaches at University of Pittsburgh School of Medicine.
- Named a Castle Connolly’s “Top Doctor” (2012).
- Received Patients’ Choice Award (2012-13) and Compassionate Doctor Recognition (2012).
- M.D. degree from George Washington University School of Medicine and Health Sciences.